ArticleInternational journal of chronic obstructive pulmonary disease2026
A Cross-Tissue Transcriptome Association Study Revealed Novel Susceptibility Genes for Chronic Obstructive Pulmonary Disease.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation, with its pathogenesis remaining elusive. Genetic factors are recognized as crucial factors in the pathogenesis of COPD. Methods: This study employed transcriptome-wide association studies (TWAS) and single cell transcriptome analysis to identify predisposition genes and potential mechanisms for COPD. Cross-tissue TWAS analysis was performed using the FinnGen R10 database and sCCA weights built from the GTEx v8. Single-tissue and single-cell validations were conducted using a FUSION method based on functional summaries. SMR and colocalization analysis were carried out. C57BL/6 mice and Beas-2b cells were exposed to smoke to simulate COPD inflammation and verify the function of the genes. The regulatory effect of genes was verified by overexpression of plasmid and siRNA. Eventually, single-cell transcriptomics was conducted to investigate the expression of susceptibility genes in lung tissue cells, while GeneMANIA analysis enhanced our insights into the functional significance of these genes. Results: A total of 125 susceptibility genes associated with COPD were identified by cross-tissue TWAS analysis. Single-tissue and single-cell TWAS, along with MAGMA validation, revealed two novel susceptibility genes, DNAJA4 and IREB2. SMR and colocalization analysis further confirmed these findings. Both mouse and cell experiments can prove that the occurrence of COPD is related to two genes. Both genes exhibit specific cell type enrichment in the lung tissue of COPD patients. The GeneMANIA analysis revealed that DNAJA4 and IREB2 potentially influence COPD risk by regulating protein folding and modification and metabolic processes, respectively. Conclusion: We identified two novel susceptibility genes (DNAJA4 and IREB2) that are causally associated with COPD. These results provide a new perspective on the genetics of COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.